Effect of the Timing of Amubarvimab/Romlusevimab (BRII-196/198) Administration on Progression to Severe Disease in Elderly Patients with COVID-19 Infection: A Retrospective Cohort Study

OBJECTIVE: Early intervention with neutralizing antibodies is considered to be effective in preventing disease progression in patients with mild to moderate COVID-19 infection. Elderly patients are the most susceptible and at a higher risk of COVID-19 infection. The present study aimed to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yonghao, Liu, Ying, Zheng, Ruiqiang, Si, Shujie, Xi, Yin, Deng, Xilong, Wang, Gang, Zhou, Liang, Li, Manshu, Wang, Ya, Zhang, Shuo, Xie, Jianfeng, Liu, Xiaoqing, Yang, Yi, Tang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240101/
https://www.ncbi.nlm.nih.gov/pubmed/37360309
http://dx.doi.org/10.1007/s44231-023-00040-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240101/
https://www.ncbi.nlm.nih.gov/pubmed/37360309
http://dx.doi.org/10.1007/s44231-023-00040-9

Ejemplares similares